EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieOpen Access · CC BY 4.0

Cost-effectiveness of a mentalisation-based treatment for antisocial personality disorder in males convicted of an offence on community probation in England and Wales: Multicentre, assessor-blind randomised controlled trial

Barbara Barrett iD, Elizabeth Simes iD, Karen Yirmiya iD, James M S Wason, Alison Frater, Angus Cameron, Stephen Butler, Zoe Hoare, Mary McMurran iD, Paul Moran, Mike Crawford, Stephen Pilling und 4 weitere

PLOS One · 22.07.2026 · 21 (7) · e0352865

DOI: 10.1371/journal.pone.0352865 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift PLOS One, online erschienen am 22.07.2026. Verfasst von Barbara Barrett und 15 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Psychiatry, Psychology & Neuroscience, King's College London, United Kingdom. Hauptthemen laut MEDLINE: Antisocial Personality Disorder, Cost-Benefit Analysis, Criminals. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health Technology Assessment Programme.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study addresses a critical gap in the evidence base for cost-effective psychological interventions for antisocial personality disorder (ASPD) in forensic settings by presenting a full trial-based economic evaluation of mentalisation-based treatment plus probation as usual (MBT-ASPD + PAU), compared to PAU alone, for males with ASPD convicted of an offence in England and Wales. The economic evaluation adopted a societal perspective, incorporating costs to health care, the criminal justice system, and the wider societal impact of offending. Outcomes were assessed 24 months post-randomisation. The primary cost–utility analysis compared costs with quality-adjusted life years (QALYs) derived from the EQ-5D-5L, while a secondary cost-effectiveness analysis compared costs with aggression outcomes measured by the Overt Aggression Scale – Modified (OAS-M). Although missing data limited definitive conclusions regarding service use, available data suggest that participants in the PAU group spent more time in custody than those in the MBT-ASPD + PAU group. Utility scores and quality of life showed minimal variation over follow-up, with no significant differences between groups. Overall costs were lower in the MBT-ASPD + PAU group, though not statistically significant. Over the 24-month period, MBT-ASPD + PAU was associated with both reduced costs and lower aggression (as reflected in OAS-M scores), indicating that each unit reduction in aggression yielded a cost saving of approximately £93. For QALYs, MBT-ASPD + PAU appeared cost-effective compared to PAU across all values a decision-maker may be willing to pay for improvements in outcome. These findings provide preliminary evidence for the potential economic value of MBT-ASPD + PAU in a forensic ASPD population, particularly in relation to aggression reduction and the associated cost savings. Trial registration This trial is registered with ISRCTN (ISRCTN 32309003).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antisocial Personality DisorderCost-Benefit AnalysisCriminalsHumansMaleWalesCost-Effectiveness AnalysisEnglandQuality-Adjusted Life YearsAdultQuality of LifeAggression

Autor:innen und Institutionen

  • Institute of Psychiatry, Psychology & Neuroscience, King's College London, United Kingdom.
  • Research Department of Clinical, Educational and Health Psychology, University College London, London, United Kingdom.
  • Anna Freud, London, United Kingdom.
  • Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • School of Law, Royal Holloway, University of London, London, United Kingdom.
  • National Probation Service London Division, London, United Kingdom.

ORCID-Profile: Barbara Barrett, Elizabeth Simes, Karen Yirmiya, Mary McMurran

Förderung

  • Health Technology Assessment Programme

Zitieren

APA

Barrett, B., Simes, E., Yirmiya, K., Wason, J. M. S., Frater, A., Cameron, A., Butler, S., Hoare, Z., McMurran, M., Moran, P., Crawford, M., Pilling, S., Allison, E., Yakeley, J., Bateman, A., & Fonagy, P. (2026). Cost-effectiveness of a mentalisation-based treatment for antisocial personality disorder in males convicted of an offence on community probation in England and Wales: Multicentre, assessor-blind randomised controlled trial. PLOS One, 21(7), e0352865. https://doi.org/10.1371/journal.pone.0352865

Vancouver

Barrett B, Simes E, Yirmiya K, Wason JMS, Frater A, Cameron A, et al. Cost-effectiveness of a mentalisation-based treatment for antisocial personality disorder in males convicted of an offence on community probation in England and Wales: Multicentre, assessor-blind randomised controlled trial. PLOS One. 2026;21(7):e0352865. doi:10.1371/journal.pone.0352865

BibTeX
@article{Barrett2026,
  author = {Barrett, Barbara and Simes, Elizabeth and Yirmiya, Karen and Wason, James M S and Frater, Alison and Cameron, Angus and Butler, Stephen and Hoare, Zoe and McMurran, Mary and Moran, Paul and Crawford, Mike and Pilling, Stephen and Allison, Elizabeth and Yakeley, Jessica and Bateman, Anthony and Fonagy, Peter},
  title = {Cost-effectiveness of a mentalisation-based treatment for antisocial personality disorder in males convicted of an offence on community probation in England and Wales: Multicentre, assessor-blind randomised controlled trial},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {7},
  pages = {e0352865},
  doi = {10.1371/journal.pone.0352865}
}
Kostenlos starten →